The FDA has approved the Solius Pro, marking it as the first home device available over-the-counter that uses UVB light. This is the same wavelength found in sunlight that prompts your skin to produce vitamin D. Now, you won’t need a prescription or a doctor’s visit to boost your vitamin D levels.
What Is the Solius Pro?
You can think of the Solius Pro as a more responsible version of a tanning bed. Unlike traditional tanning beds that expose your skin to a broad range of UV rays—often leading to burns and long-term damage—this device emits a narrow band of UVB light. This specific wavelength is what your skin needs to synthesize vitamin D. While previous UVB light panels required a doctor’s prescription and were usually found in clinics, the FDA’s clearance means anyone can now buy and use one at home.
Solius, the company behind this device, specializes in phototherapy, which uses specific wavelengths of light to treat various medical conditions. The “Pro” model is aimed at consumers for regular home use.
Why Does This Matter?
Vitamin D deficiency is a widespread issue. Estimates indicate that around 1 billion people worldwide suffer from low vitamin D levels. In the U.S., roughly 35% of adults are deficient. Low vitamin D is associated with weakened bones, immune issues, fatigue, and even depression.
Many people try to address this deficiency with supplements or by spending more time outdoors. However, both methods have their drawbacks. Vitamin D supplements can be absorbed inconsistently, while getting enough sunlight can be a challenge for people in northern climates, those working indoors, or individuals with darker skin tones who need more sun exposure to produce the same amount of vitamin D.
A home UVB panel could provide a controlled, consistent way to stimulate your body’s natural vitamin D production. You get the benefits of sunlight without worrying about weather, seasons, or geographical limitations.
The Safety Angle
You might wonder: if UV light can lead to skin cancer, why did the FDA approve a device that emits it?
The answer lies in the dosage. The Solius Pro is designed to give a sub-erythemal dose. This means it emits a level of UVB light that’s low enough to avoid causing redness or burning. The device carefully controls the duration and intensity of exposure, allowing users to gain benefits without risking skin damage. The FDA evaluated this safety profile before giving the green light for at-home use.
However, individuals with certain skin conditions, a history of skin cancer, or sensitivity to UV light should consult a doctor before using any phototherapy device.
| Metric | Figure |
|---|---|
| Estimated people globally with low vitamin D | ~1 billion |
| U.S. adults with vitamin D deficiency | ~35% |
| FDA classification | Over-the-counter (no prescription needed) |
| Previous availability of UVB panels | Prescription / clinical use only |
| Target exposure type | Sub-erythemal (no redness or burning) |
What This Means
For everyday users, the FDA’s clearance opens up a previously closed door. If you live in places like Seattle or Minneapolis, where sunlight can be scarce for months, a device like this could help you get what your body misses out on during the fall and winter. Those who work night shifts, stay indoors for health reasons, or struggle with taking supplements now have a viable alternative.
This approval also reflects a shift in the FDA’s approach to phototherapy devices. Granting clearance for a UVB panel for home use without a prescription is a significant regulatory step. It shows the agency believes the built-in safety controls make the device suitable for unsupervised consumers.
However, there’s a practical hurdle: price. Dedicated phototherapy devices have often been pricey, and the Solius Pro likely won’t come cheap. Until the retail price is confirmed, cost could be a major barrier to widespread use.
Community Reactions
“This is genuinely exciting for those of us in northern states. I’ve been buying D3 supplements for years and my levels are still low. If this actually works consistently I’d pay for it.”
“The FDA cleared it for OTC which is huge, but I want to see independent testing on whether the dose is actually enough to move the needle on blood levels. Marketing and reality aren’t always the same thing.”
What To Watch
- Pricing announcement: Solius hasn’t confirmed the retail price yet. Keep an eye on this figure, as it will impact how accessible the device is for most households.
- Retail availability: If the Solius Pro shows up in major retailers like Best Buy, CVS, or Amazon, it will indicate how broadly Solius plans to market it beyond early adopters.
- Clinical follow-up studies: Independent researchers will likely conduct trials to see if home UVB sessions effectively raise blood vitamin D levels (measured as 25-hydroxyvitamin D) compared to traditional supplements. The results could either support or complicate the device’s claims.
- Competitor response: With the FDA establishing a regulatory path for OTC home UVB panels, expect other phototherapy companies to seek similar approvals.
Sources: CNET — FDA Clears Solius Pro
Daniel Park
Daniel Park covers AI, cloud infrastructure, and enterprise software for Explosion.com. A former software engineer who transitioned to technology journalism 5 years ago, Daniel brings technical depth to his reporting on artificial intelligence, startup funding rounds, and the companies building the future of computing. He breaks down complex AI developments and business strategies into clear, actionable insights for readers who want to understand how technology is reshaping industries.
